Varaico: Literature-Extracted Genetic Variants

Gene:LMNA
Variant:p.E161K
Back to variants list

LMNA

NM_170707.4:p.E161K

Associated Papers

Clinical Spectrum of Arrhythmogenic Entities in Spanish Children Carrying Deleterious SCN5A Variants.

Martínez-Barrios E et al.

International Journal of Molecular Sciences, 2026

Major arrhythmias in non-dilated left ventricular cardiomyopathy: a novel prediction score.

Peretto G et al.

European Heart Journal, 2026

Cardiomyopathies, heart rhythm and conduction disorders as phenotypic manifestation of genetic variants in large cohort of cardiac patients: results of whole-genome study.

Rimskaya EM et al.

Gene, 2026

Cardiovascular prognostic impact of missense vs nonmissense lamin A/C variants: A systematic review and meta-analysis.

Guaricci AI et al.

Heart Rhythm, 2026

Arrhythmic genotypes in dilated cardiomyopathy and risk of advanced heart failure.

Mora-Ayestarán N et al.

European Heart Journal, 2025

40878535 (PubMed )
Supplement: ehaf605_supplementary_data.zip › S13._Variant_classification.xlsx › Variant_classification

Nuclear-lamin-guided plastic positioning and folding of the human genome.

Wang Z et al.

Cell Reports, 2025

Oxford Nanopore Technologies [ONT] Sequencing: Clinical Validation in Genetically Heterogeneous Disorders.

Urtis M et al.

Genes, 2025

41300778 (PubMed )
Supplement: genes-16-01325-s001.zip › genes-3897287-supplementary.pdf

LMNA-related cardiomyopathy: From molecular pathology to cardiac gene therapy.

Wang Z et al.

Journal of Advanced Research, 2025

Prevalence of Pathogenic and Likely Pathogenic Variants Associated with Cardiovascular Diseases in Russian Adults and Long-Living Individuals.

Dzhumaniiazova I et al.

Genes, 2025

41153446 (PubMed )
Supplement: genes-16-01228-s001.zip › genes-3881151-supplementary_tables.xlsx › S1

Liquid-liquid phase separation of lamin drives altered chromatin organization in cardiomyopathic mutations of lamin A.

Nath S et al.

Nucleic Acids Research, 2025

Computational analysis of congenital heart disease associated SNPs: unveiling their impact on the gene regulatory system.

Vashisht S et al.

Bmc Genomics, 2025

39838281 (PubMed )
Supplement: 12864_2025_11232_MOESM4_ESM.xlsx › ClinVar_CHD-SNPs_uniq

Changes in Chromatin Organisation and Mechanotransduction Mediated by Mutant Lamins in Laminopathies.

Nath S et al.

Sub-cellular Biochemistry, 2025

Cold case files: A tale of three sisters - solved by genetic testing with implications for LMNA cardiomyopathy.

Vlay SC

Pacing and Clinical Electrophysiology : Pace, 2024

The structure and function of lamin A/C: Special focus on cardiomyopathy and therapeutic interventions.

Tiwari V et al.

Life Sciences, 2024

Primate Model Carrying LMNA Mutation Develops Dilated Cardiomyopathy.

Luo X et al.

Jacc. Basic to Translational Science, 2024

38559624 (PubMed )
Supplement: mmc1.docx

Truncated titin is structurally integrated into the human dilated cardiomyopathic sarcomere.

Kellermayer D et al.

The Journal of Clinical Investigation, 2024

37962957 (PubMed )
Supplement: jci-134-169753-s012.xlsx › Munka1

Intermediate filaments in the heart: The dynamic duo of desmin and lamins orchestrates mechanical force transmission.

West G et al.

Current Opinion in Cell Biology, 2023

Identification of variants in genes associated with hypertrophic cardiomyopathy in Mexican patients.

García-Vielma C et al.

Molecular Genetics and Genomics : Mgg, 2023

Frequency of actionable secondary findings in 7472 Korean genomes derived from the National Project of Bio Big Data pilot study.

Kim Y et al.

Human Genetics, 2023

37728764 (PubMed )
Supplement: 439_2023_2592_MOESM2_ESM.xlsx › Sheet1

An alpha-helix variant p.Arg156Pro in LMNA as a cause of hereditary dilated cardiomyopathy: genetics and bioinfomatics exploration.

Chang L et al.

Bmc Medical Genomics, 2023

The penetrance of rare variants in cardiomyopathy-associated genes: A cross-sectional approach to estimating penetrance for secondary findings.

McGurk KA et al.

American Journal of Human Genetics, 2023

37652022 (PubMed )
Supplement: mmc3.xlsx › Table_S9

Generation of human induced pluripotent stem cell line EURACi015-A from a patient affected by dilated cardiomyopathy carrying the Lamin A/C p.Glu161Lys mutation.

Cattelan G et al.

Stem Cell Research, 2023

Caenorhabditis elegans models for striated muscle disorders caused by missense variants of human LMNA.

Gregory EF et al.

Plos Genetics, 2023

Modulation of cytoskeleton in cardiomyopathy caused by mutations in LMNA gene.

Chatzifrangkeskou M et al.

American Journal of Physiology. Cell Physiology, 2023

Epigenetics in LMNA-Related Cardiomyopathy.

Wang Y et al.

Cells, 2023

Diagnostic yield of genetic testing in a multinational heterogeneous cohort of 2088 DCM patients.

Heliö K et al.

Frontiers in Cardiovascular Medicine, 2023

37795486 (PubMed )
Supplement: Table1.xlsx › Sheet1

Genotype-Phenotype Correlations in Human Diseases Caused by Mutations of LINC Complex-Associated Genes: A Systematic Review and Meta-Summary.

Storey EC et al.

Cells, 2022

36552829 (PubMed )
Supplement: cells-11-04065-s001.zip › Storey___Fuller_Supplementary_Materials_S2_Data_extraction.xlsx › Lamins

The E262K mutation in Lamin A links nuclear proteostasis imbalance to laminopathy-associated premature aging.

Ghosh DK et al.

Aging Cell, 2022

Allele-specific differential regulation of monoallelically expressed autosomal genes in the cardiac lineage.

Balasooriya GI et al.

Nature Communications, 2022

36216821 (PubMed )
Supplement: 41467_2022_33722_MOESM6_ESM.xlsx › File_1

Pathogenic variants damage cell composition and single cell transcription in cardiomyopathies.

Reichart D et al.

Science (new York, N.y.), 2022

35926050 (PubMed )
Supplement: NIHMS1835045-supplement-Supp__table_1.xlsx › disease_samples

Personalized Medicine Approach in a DCM Patient with LMNA Mutation Reveals Dysregulation of mTOR Signaling.

Neupane B et al.

Journal of Personalized Medicine, 2022

Pregnancy and Progression of Cardiomyopathy in Women With LMNA Genotype-Positive.

Castrini AI et al.

Journal of the American Heart Association, 2022

35434999 (PubMed )
Supplement: JAH3-11-e024960-s001.pdf

Atomic Force Microscopy (AFM) Applications in Arrhythmogenic Cardiomyopathy.

Peña B et al.

International Journal of Molecular Sciences, 2022

Role of Nuclear Lamin A/C in the Regulation of Nav1.5 Channel and Microtubules: Lesson From the Pathogenic Lamin A/C Variant Q517X.

De Zio R et al.

Frontiers in Cell and Developmental Biology, 2022

Most myopathic lamin variants aggregate: a functional genomics approach for assessing variants of uncertain significance.

Anderson CL et al.

Npj Genomic Medicine, 2021

34862408 (PubMed )
Supplement: 41525_2021_265_MOESM1_ESM.pdf

Clinical Features of LMNA-Related Cardiomyopathy in 18 Patients and Characterization of Two Novel Variants.

Ferradini V et al.

Journal of Clinical Medicine, 2021

Timing of pacemaker and ICD implantation in LMNA mutation carriers.

Ollila LH et al.

Open Heart, 2021

Laminopathies' Treatments Systematic Review: A Contribution Towards a 'Treatabolome'.

Atalaia A et al.

Journal of Neuromuscular Diseases, 2021

Distinct Myocardial Transcriptomic Profiles of Cardiomyopathies Stratified by the Mutant Genes.

Sielemann K et al.

Genes, 2020

33260757 (PubMed )
Supplement: genes-11-01430-s001.zip › genes-997621-SI › File_S1.pdf

Reevaluating the Genetic Contribution of Monogenic Dilated Cardiomyopathy.

Mazzarotto F et al.

Circulation, 2020

31983221 (PubMed )
Supplement: cir-141-387-s002.xlsx › Table_S6

Altered microtubule structure, hemichannel localization and beating activity in cardiomyocytes expressing pathologic nuclear lamin A/C.

Borin D et al.

Heliyon, 2020

Viscoelastic behavior of cardiomyocytes carrying LMNA mutations.

Borin D et al.

Biorheology, 2020

1–50 of 109 papers
Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."